wasn't there a report from asco reporting a shortage of oncologists in 2020? that could be possibly why they are increasing spots?
Yes, ASCO is projecting that the incidence in cancer will nearly double by 2020 as the population grows and gets older, and therefore there will be a shortage of oncologists in the near future. I'm not sure if this largely pertains to medical oncologists, or if all oncologists are included in this prediction (although it would make sense that everyone who treats cancer would be impacted).
I think from discussions that I've had with program directors, the total amount of spots in rad onc is not solely tied to future supply and demand issues of the rad onc job market (although this certainly plays a role- hopefully a major role). Each time a program applies for more residency spots, their application is considered on an individual basis. If program X gets approved for more spots, it doesn't have to correspond with a decrease in spots at program Y. Overall, no one wants to grow too fast, but I think that generally, radiation oncology is seen as a growing field.
One of the major criteria for approving additional spots is the clinical volume of the institution. If the volume of the academic institution is felt to be inadequate to support additional trainees, then their application will be rejected. Because many academic institutions are growing, treating more patients, building new facilities, buying new equipment, opening new cancer centers, hiring more faculty, etc., many are also applying for additional residency spots.
Additionally, more and more programs are offering dedicated research time during residency. Therefore, the clinical volume can be spread across more residents. For example, MSKCC now offers one full year of protected research instead of 3 months. Therefore, they have increased their residency program from 16 residents to 20 residents (20-5 in lab = 15). I actually am not positive that this is the sole reason that they increased the size of their residency class (I have no inside information), but it makes sense given the timing of the increase and the hiring of Simon Powell. As more programs support research tracks and the Holman pathway, they can make an argument that they can support more residents for a given clinical volume.
The job market was extremely tight this year from what I understand, but I think this had as much to do with economic uncertainty as it did with an over-supply of graduating PGY-5's. I think that many private practices and academic institutions were reluctant to hire new docs given the overall state of the economy, the uncertainty of the Obama health care reform, and the pending CMS cuts (that later were dodged). In addition, many practicing rad oncs had their 401k's decimated by the stock market, and therefore were less likely to retire. There were many reasons for the tight job market, especially in certain areas of the country.
I think that job saturation is a major concern in certain markets. However, I think that there are more indications and therapeutic options in radiation oncology than ever before, and I think that the field will continue to grow in the forseeable future.